Modelling Parkinson's Disease in Drosophila

NeuroMolecular Medicine

Volumn 11, Issue 4, 2009, Pages 268-280

  Botella, José A ^a   Bayersdorfer, Florian ^a   Gmeiner, Florian ^a   Schneuwly, Stephan ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Synuclein; Drosophila; Oxidative stress; Parkin; Parkinson's disease; PINK1; Rotenone

Indexed keywords

ALPHA SYNUCLEIN; DJ 1 PROTEIN; DOPAMINE; ENZYME; LEUCINE RICH REPEAT KINASE 2; NEUROTOXIN; PARAQUAT; PARKIN; PTEN INDUCED PUTATIVE KINASE 1; SERINE PROTEINASE OMI; UNCLASSIFIED DRUG;

COMPREHENSION; DISEASE COURSE; DISEASE MODEL; DROSOPHILA; GENETIC MODEL; INTROSPECTION; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW;

ALPHA-SYNUCLEIN; ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; HUMANS; MITOCHONDRIA; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN-SERINE-THREONINE KINASES; SERINE PROTEASES; SUPEROXIDES; UBIQUITIN-PROTEIN LIGASES;

ANIMALIA; INVERTEBRATA;

EID: 72949108454     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12017-009-8098-6     Document Type: Review

References (82)

1. S Asakawa N Hattori H Matsumine, et al. 1998 Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 392 605 608 10.1038/33416 9560156 (Pubitemid 28207717)
2. A Ascherio H Chen MG Weisskopf, et al. 2006 Pesticide exposure and risk for Parkinson's disease Annals of Neurology 60 197 203 10.1002/ana.20904 16802290 (Pubitemid 44182394)
3. PK Auluck HY Chan JQ Trojanowski, et al. 2002 Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease Science 295 865 868 10.1126/science.1067389 11823645 (Pubitemid 34118369)
4. PK Auluck MC Meulener NM Bonini 2005 Mechanisms of suppression of {alpha}-synuclein neurotoxicity by geldanamycin in Drosophila The Journal of Biological Chemistry 280 2873 2878 10.1074/jbc.M412106200 15556931 (Pubitemid 40189396)
5. YJ Bae KS Park SJ Kang 2003 Genomic organization and expression of parkin in Drosophila melanogaster Experimental and Molecular Medicine 35 393 402 14646593
6. S Bharath M Hsu D Kaur, et al. 2002 Glutathione, iron and Parkinson's disease Biochemical Pharmacology 64 1037 1048 10.1016/S0006-2952(02)01174-7 12213603 (Pubitemid 35232279)
7. JA Botella F Bayersdorfer S Schneuwly 2008 Superoxide dismutase overexpression protects dopaminergic neurons in a Drosophila model of Parkinson's disease Neurobiology of Diseases 30 65 73 10.1016/j.nbd.2007.11.013
8. J Bové D Prou C Perier, et al. 2005 Toxin-induced models of Parkinson's disease NeuroRx 2 484 494 10.1602/neurorx.2.3.484 16389312 (Pubitemid 41444882)
9. AH Brand N Perrimon 1993 Targeted gene expression as a means of altering cell fates and generating dominant phenotypes Development 118 401 415 8223268
10. PR Castello DA Drechsel M Patel 2007 Mitochondria are a major source of paraquat-induced reactive oxygen species production in the brain The Journal of Biological Chemistry 282 14186 14193 10.1074/jbc.M700827200 17389593 (Pubitemid 47100444)
11. GH Cha S Kim J Park, et al. 2005 Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila Proceedings of the National Academy of Sciences of the United States of America 102 10345 11050 10.1073/pnas. 0500346102 16002472 (Pubitemid 41023373)
12. A Chaudhuri K Bowling C Funderburk, et al. 2007 Interaction of genetic and environmental factors in a Drosophila parkinsonism model Journal of Neuroscience 27 2457 2467 10.1523/JNEUROSCI.4239-06.2007 17344383 (Pubitemid 46393605)
13. L Chen MB Feany 2005 Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease Nature Neuroscience 8 657 663 10.1038/nn1443 15834418 (Pubitemid 40594208)
14. IE Clark MW Dodson C Jiang, et al. 2006 Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin Nature 441 1162 1166 10.1038/nature04779 16672981 (Pubitemid 43990738)
15. AA Cooper AD Gitler A Cashikar, et al. 2006 Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models Science 313 324 328 10.1126/science.1129462 16794039 (Pubitemid 44480951)
16. H Coulom S Birman 2004 Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster Journal of Neuroscience 24 10993 10998 10.1523/JNEUROSCI.2993-04.2004 15574749 (Pubitemid 39602410)
17. F Darios O Corti CB Lücking, et al. 2003 Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death Human Molecular Genetics 12 517 526 10.1093/hmg/ddg044 12588799 (Pubitemid 36305590)
18. H Deng MW Dodson H Huang, et al. 2008 The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila Proceedings of the National Academy of Sciences of the United States of America 105 14503 14508 10.1073/pnas.0803998105 18799731
19. C Dixon N Mathias RM Zweig, et al. 2005 Alpha-synuclein targets the plasma membrane via the secretory pathway and induces toxicity in yeast Genetics 170 47 59 10.1534/genetics.104.035493 15744056 (Pubitemid 40799970)
20. M Emdadul-Haque M Asanuma Y Higashi, et al. 2003 Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells Biochimica et Biophysica Acta 1619 39 52 12495814
21. MB Feany WW Bender 2000 A Drosophila model of Parkinson's disease Nature 404 394 398 10.1038/35006074 10746727 (Pubitemid 30164341)
22. TR Flower C Clark-Dixon C Metoyer, et al. 2007 YGR198w (YPP1) targets A30P alpha-synuclein to the vacuole for degradation Journal of Cell Biology 177 1091 1104 10.1083/jcb.200610071 17576801 (Pubitemid 46955712)
23. F Friggi-Grelin H Coulom M Meller D Gomez J Hirsh S Birman 2003 Targeted gene expression in Drosophila dopaminergic cells using regulatory sequences from tyrosine hydroxylase Journal of Neurobiology 54 618 627 10.1002/neu.10185 12555273 (Pubitemid 36232667)
24. H Fujiwara M Hasegawa N Dohmae, et al. 2002 alpha-Synuclein is phosphorylated in synucleinopathy lesions Nature Cell Biology 4 160 164 10.1038/ncb841 11813001 (Pubitemid 34993702)
25. JC Greene AJ Whitworth LA Andrews, et al. 2005 Genetic and genomic studies of Drosophila parkin mutants implicate oxidative stress and innate immune responses in pathogenesis Human Molecular Genetics 14 799 811 10.1093/hmg/ddi074 15689351 (Pubitemid 40403276)
26. JC Greene AJ Whitworth I Kuo, et al. 2003 Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants Proceedings of the National Academy of Sciences of the United States of America 100 4078 4083 10.1073/pnas.0737556100 12642658 (Pubitemid 36418160)
27. C Gruenewald JA Botella F Bayersdorfer, et al. 2009 Hyperoxia-induced neurodegeneration as a tool to identify neuroprotective genes in Drosophila melanogaster Free Radical Biology and Medicine 46 1668 1676 10.1016/j. freeradbiomed.2009.03.025 19345730
28. JM Horowitz VA Vernace JJ Myers, et al. 2001 Immunodetection of Parkin protein in vertebrate and invertebrate brains: A comparative study using specific antibodies Journal of Chemical Neuroanatomy 21 75 93 10.1016/S0891-0618(00)00111-3 11173222 (Pubitemid 32155393)
29. Y Imai S Gehrke HQ Wang, et al. 2008 Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila EMBO Journal 27 2432 2443 10.1038/emboj.2008.163 18701920
30. JM Jones P Datta SM Srinivasula, et al. 2003 Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice Nature 425 721 727 10.1038/nature02052 14534547 (Pubitemid 37314315)
31. Y Kim J Park S Kim, et al. 2008 PINK1 controls mitochondrial localization of Parkin through direct phosphorylation Biochemical and Biophysical Research Communications 377 975 980 10.1016/j.bbrc.2008.10.104 18957282
32. RH Kim M Peters Y Jang, et al. 2005 DJ-1, a novel regulator of the tumor suppressor PTEN Cancer Cell 7 263 273 10.1016/j.ccr.2005.02.010 15766664 (Pubitemid 40568685)
33. J Klucken Y Shin E Masliah, et al. 2004 Hsp70 reduces alpha-synuclein aggregation and toxicity The Journal of Biological Chemistry 279 25497 25502 10.1074/jbc.M400255200 15044495 (Pubitemid 38756808)
34. R Kruger W Kuhn T Muller, et al. 1998 Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease Nature Genetics 18 106 108 10.1038/ng0298-106 9462735
35. E Lavara-Culebras N Paricio 2007 Drosophila DJ-1 mutants are sensitive to oxidative stress and show reduced lifespan and motor deficits Gene 400 158 165 10.1016/j.gene.2007.06.013 17651920 (Pubitemid 47284741)
36. SB Lee W Kim S Lee, et al. 2007 Loss of LRRK2/PARK8 induces degeneration of dopaminergic neurons in Drosophila Biochemical and Biophysical Research Communications 358 534 539 10.1016/j.bbrc.2007.04.156 17498648 (Pubitemid 46755736)
37. AK Liou RK Leak L Li, et al. 2008 Wild-type LRRK2 but not its mutant attenuates stress-induced cell death via ERK pathway Neurobiology of Diseases 32 116 124 10.1016/j.nbd.2008.06.016
38. Z Liu X Wang Y Yu, et al. 2008 A Drosophila model for LRRK2-linked parkinsonism Proceedings of the National Academy of Sciences of the United States of America 105 2693 2698 10.1073/pnas.0708452105 18258746
39. J Lotharius P Brundin 2002 Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease Human Molecular Genetics 11 2395 2407 10.1093/hmg/11.20.2395 12351575
40. LM Martins A Morrison K Klupsch, et al. 2004 Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice Molecular and Cellular Biology 24 9848 9862 10.1128/MCB.24.22.9848-9862.2004 15509788 (Pubitemid 39458812)
41. FM Menzies SC Yenisetti KT Min 2005 Roles of Drosophila DJ-1 in survival of dopaminergic neurons and oxidative stress Current Biology 15 1578 1582 10.1016/j.cub.2005.07.036 16139214 (Pubitemid 41219598)
42. M Meulener AJ Whitworth CE Armstrong-Gold, et al. 2005 Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease Current Biology 15 1572 1577 10.1016/j.cub.2005.07.064 16139213 (Pubitemid 41219597)
43. DJ Moore L Zhang J Troncoso, et al. 2005 Association of DJ-1 and Parkin mediated by pathogenic DJ-1 mutations and oxidative stress Human Molecular Genetics 14 71 84 10.1093/hmg/ddi007 15525661 (Pubitemid 40123464)
44. EV Mosharov RG Staal J Bové, et al. 2006 Alpha-synuclein overexpression increases cytosolic catecholamine concentration Journal of Neuroscience 26 9304 9311 10.1523/JNEUROSCI.0519-06.2006 16957086 (Pubitemid 44359856)
45. D Narendra A Tanaka DF Suen, et al. 2008 Parkin is recruited selectively to impaired mitochondria and promotes their autophagy Journal of Cell Biology 183 795 803 10.1083/jcb.200809125 19029340
46. D Narendra A Tanaka DF Suen, et al. 2009 Parkin-induced mitophagy in the pathogenesis of Parkinson disease Autophagy 5 706 708 19377297
47. DR Nässel K Elekes 1992 Aminergic neurons in the brain of blowflies and Drosophila: Dopamine- and tyrosine hydroxylase-immunoreactive neurons and their relationship with putative histaminergic neurons Cell and Tissue Research 267 147 167 10.1007/BF00318701 1346506
48. C Paisán-Ruíz S Jain EW Evans, et al. 2004 Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease Neuron 44 595 600 10.1016/j.neuron.2004.10.023 15541308 (Pubitemid 39531224)
49. J Park SY Kim GH Cha, et al. 2005 Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction Gene 361 133 139 10.1016/j.gene.2005.06. 040 16203113 (Pubitemid 41506941)
50. J Park G Lee J Chung 2009 The PINK1-Parkin pathway is involved in the regulation of mitochondrial remodeling process Biochemical and Biophysical Research Communications 378 518 523 10.1016/j.bbrc.2008.11.086 19056353
51. J Park SB Lee S Lee, et al. 2006 Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin Nature 441 1157 1161 10.1038/nature04788 16672980 (Pubitemid 43990737)
52. SS Park EM Schulz D Lee 2007 Disruption of dopamine homeostasis underlies selective neurodegeneration mediated by alpha-synuclein European Journal of Neuroscience 26 3104 3112 10.1111/j.1460-9568.2007.05929.x 18005066 (Pubitemid 350135175)
53. RG Pendleton F Parvez M Sayed, et al. 2002 Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster Journal of Pharmacology and Experimental Therapeutics 300 91 96 10.1124/jpet.300.1.91 11752102 (Pubitemid 34028513)
54. Y Pesah H Burgess B Middlebrooks, et al. 2005 Whole-mount analysis reveals normal numbers of dopaminergic neurons following misexpression of alpha-Synuclein in Drosophila Genesis 41 154 159 10.1002/gene.20106 15789427 (Pubitemid 40656685)
55. MH Polymeropoulos C Lavedan E Leroy, et al. 1997 Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 2045 2047 10.1126/science.276.5321.2045 9197268 (Pubitemid 27443610)
56. AC Poole RE Thomas LA Andrews 2008 The PINK1/Parkin pathway regulates mitochondrial morphology Proceedings of the National Academy of Sciences of the United States of America 105 1638 1643 10.1073/pnas.0709336105 18230723 (Pubitemid 351346567)
57. MG Riparbelli G Callaini 2007 The Drosophila parkin homologue is required for normal mitochondrial dynamics during spermiogenesis Developmental Biology 303 108 120 10.1016/j.ydbio.2006.10.038 17123504 (Pubitemid 46241091)
58. OA Ross AI Soto C Vilariño-Güell, et al. 2008 Genetic variation of Omi/HtrA2 and Parkinson's disease Parkinsonism and Related Disorders 14 539 543 10.1016/j.parkreldis.2008.08.003 18790661
59. TK Sang HY Chang GM Lawless, et al. 2007 A Drosophila model of mutant human parkin-induced toxicity demonstrates selective loss of dopaminergic neurons and dependence on cellular dopamine Journal of Neuroscience 27 981 992 10.1523/JNEUROSCI.4810-06.2007 17267552 (Pubitemid 46203305)
60. TB Sherer JH Kim R Betarbet, et al. 2003 Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation Experimental Neurology 179 9 16 10.1006/exnr.2002.8072 12504863 (Pubitemid 36062614)
61. J Simón-Sánchez AB Singleton 2008 Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls Human Molecular Genetics 17 1988 1993 10.1093/hmg/ddn096 18364387 (Pubitemid 351865847)
62. AB Singleton M Farrer J Johnson, et al. 2003 alpha-Synuclein locus triplication causes Parkinson's disease Science 302 841 10.1126/science.1090278 14593171 (Pubitemid 37339619)
63. KM Strauss LM Martins H Plun-Favreau, et al. 2005 Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease Human Molecular Genetics 14 2099 2111 10.1093/hmg/ddi215 15961413 (Pubitemid 41418010)
64. AM Todd BE Staveley 2008 Pink1 suppresses alpha-synuclein-induced phenotypes in a Drosophila model of Parkinson's disease Genome 51 1040 1046 10.1139/G08-085 19088817
65. K Trinh K Moore PD Wes, et al. 2008 Induction of the phase II detoxification pathway suppresses neuron loss in Drosophila models of Parkinson's disease Journal of Neuroscience 28 465 472 10.1523/JNEUROSCI.4778- 07.2008 18184789
66. EM Valente PM Abou-Sleiman V Caputo 2004 Hereditary early-onset Parkinson's disease caused by mutations in PINK1 Science 304 1158 1160 10.1126/science.1096284 15087508 (Pubitemid 38661852)
67. C Wang R Lu X Ouyang, et al. 2007 Drosophila overexpressing parkin R275W mutant exhibits dopaminergic neuron degeneration and mitochondrial abnormalities Journal of Neuroscience 27 8563 8570 10.1523/JNEUROSCI.0218-07.2007 17687034 (Pubitemid 47254271)
68. D Wang L Qian H Xiong, et al. 2006 Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila Proceedings of the National Academy of Sciences of the United States of America 103 13520 13525 10.1073/pnas.0604661103 16938835 (Pubitemid 44380140)
69. D Wang B Tang G Zhao, et al. 2008 Dispensable role of Drosophila ortholog of LRRK2 kinase activity in survival of dopaminergic neurons Molecular Neurodegeneration 3 3 10.1186/1750-1326-3-3 18257932
70. JM Warrick HY Chan GL Gray-Board, et al. 1999 Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70 Nature Genetics 23 425 428 10.1038/70532 10581028
71. R Wassef R Haenold A Hansel, et al. 2007 Methionine sulfoxide reductase A and a dietary supplement S-methyl-l-cysteine prevent Parkinson's-like symptoms Journal of Neuroscience 27 12808 12816 10.1523/JNEUROSCI.0322-07.2007 18032652 (Pubitemid 350159591)
72. AJ Whitworth JR Lee VM Ho, et al. 2008 Rhomboid-7 and HtrA2/Omi act in a common pathway with the Parkinson's disease factors Pink1 and Parkin Disease Models and Mechanisms 1 168 174 10.1242/dmm.000109 19048081
73. AJ Whitworth DA Theodore JC Greene, et al. 2005 Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease Proceedings of the National Academy of Sciences of the United States of America 102 8024 8029 10.1073/pnas.0501078102 15911761 (Pubitemid 40781056)
74. AJ Whitworth PD Wes LJ Pallanck 2006 Drosophila models pioneer a new approach to drug discovery for Parkinson's disease Drug Discovery Today 11 119 126 10.1016/S1359-6446(05)03693-7 16533709 (Pubitemid 43375962)
75. Y Yang S Gehrke ME Haque, et al. 2005 Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling Proceedings of the National Academy of Sciences of the United States of America 102 13670 13675 10.1073/pnas.0504610102 16155123 (Pubitemid 41420906)
76. Y Yang S Gehrke Y Imai, et al. 2006 Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin Proceedings of the National Academy of Sciences of the United States of America 103 10793 10798 10.1073/pnas.0602493103 16818890 (Pubitemid 44078055)
77. Y Yang I Nishimura Y Imai, et al. 2003 Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila Neuron 37 911 924 10.1016/S0896-6273(03)00143-0 12670421 (Pubitemid 36398298)
78. Y Yang Y Ouyang L Yang, et al. 2008 Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery Proceedings of the National Academy of Sciences of the United States of America 105 7070 7075 10.1073/pnas.0711845105 18443288 (Pubitemid 351754531)
79. S Yu K Ueda P Chan 2005 Alpha-synuclein and dopamine metabolism Molecular Neurobiology 31 243 254 10.1385/MN:31:1-3:243 15953825 (Pubitemid 41271207)
80. J Yun JH Cao MW Dodson, et al. 2008 Loss-of-function analysis suggests that Omi/HtrA2 is not an essential component of the PINK1/PARKIN pathway in vivo Journal of Neuroscience 28 14500 14510 10.1523/JNEUROSCI.5141-08.2008 19118185
81. JJ Zarranz J Alegre JC Gómez-Esteban, et al. 2004 The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia Annals of Neurology 55 164 173 10.1002/ana.10795 14755719 (Pubitemid 38166992)
82. A Zimprich S Biskup P Leitner, et al. 2004 Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology Neuron 44 601 607 10.1016/j.neuron.2004.11.005 15541309 (Pubitemid 39531225)